GASTROESOPHAGEAL CANCER (GC)
Clinical trials for GASTROESOPHAGEAL CANCER (GC) explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER (GC) trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER (GC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers with genetic weakness
Disease control Recruiting nowThis early-stage trial is testing a new drug called IDE892, alone or with another drug (IDE397), in people with advanced solid tumors that have a specific genetic deletion (MTAP). The study aims to find safe doses and see if the drugs shrink tumors. It includes 260 adults with ca…
Matched conditions: GASTROESOPHAGEAL CANCER (GC)
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New cancer drug CTX-10726 enters first human tests
Disease control Recruiting nowThis early-stage trial tests an experimental drug called CTX-10726 in about 70 people with advanced gastroesophageal, liver, endometrial, or kidney cancers that have stopped responding to standard treatments. The main goal is to check safety and find the right dose. Participants …
Matched conditions: GASTROESOPHAGEAL CANCER (GC)
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New scan could spot hidden cancers faster and more accurately
Diagnosis Recruiting nowThis study tests a new type of PET/CT scan (using [68Ga]Ga-FAPI-46) to see if it can find and stage gastroesophageal and pancreatic cancers better than current scans. About 90 adults with these cancers will get the new scan before surgery or treatment, and some will have a second…
Matched conditions: GASTROESOPHAGEAL CANCER (GC)
Phase: PHASE2 • Sponsor: Barbara Malene Fischer • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC